FALLICA, ANTONINO NICOLO'

FALLICA, ANTONINO NICOLO'  

SCIENZE DEL FARMACO E DELLA SALUTE (DSFS) (Department of Drug and Health Sciences)  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.02 secondi).
Titolo Data di pubblicazione Autore(i) File
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent in Vitro Antiproliferative Activity 1-gen-2021 Fallica, A. N.; Sorrenti, V.; D'Amico, A. G.; Salerno, L.; Romeo, G.; Intagliata, S.; Consoli, V.; Floresta, G.; Rescifina, A.; D'Agata, V.; Vanella, L.; Pittala, V.
From far west to east: Joining the molecular architecture of imidazole-like ligands in ho-1 complexes 1-gen-2021 Floresta, G.; Fallica, A. N.; Patamia, V.; Sorrenti, V.; Greish, K.; Rescifina, A.; Pittala, V.
Growing the molecular architecture of imidazole-like ligands in HO-1 complexes 1-gen-2021 Floresta, G.; Fallica, A. N.; Salerno, L.; Sorrenti, V.; Pittala, V.; Rescifina, A.
Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors 1-gen-2019 Intagliata, Sebastiano; Salerno, Loredana; Ciaffaglione, Valeria; Leonardi, Carmen; Fallica, ANTONINO NICOLO'; Carota, Giuseppe; Amata, Emanuele; Marrazzo, Agostino; Pittalà, Valeria; Romeo, Giuseppe
Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region 1-gen-2020 Floresta, Giuseppe; Fallica, Antonino N.; Romeo, Giuseppe; Sorrenti, Valeria; Salerno, Loredana; Rescifina, Antonio; Pittalà, Valeria
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders 1-gen-2018 Barbaraci, Carla; Dichiara, Maria; Turnaturi, Rita; Fallica Antonino, N; Arena, Emanuela; Prezzavento, Orazio; Amata, Emanuele; Marrazzo, Agostino
Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation 1-gen-2021 Salerno, L.; Vanella, L.; Sorrenti, V.; Consoli, V.; Ciaffaglione, V.; Fallica, A. N.; Canale, V.; Zajdel, P.; Pignatello, R.; Intagliata, S.
The potential role of sildenafil in cancer management through epr augmentation 1-gen-2021 Haider, M.; Elsherbeny, A.; Pittala, V.; Fallica, A. N.; Alghamdi, M. A.; Greish, K.
The Promise of Nanotechnology in Personalized Medicine 1-gen-2022 Alghamdi, M. A.; Fallica, A. N.; Virzi, N.; Kesharwani, P.; Pittala, V.; Greish, K.
Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective 1-gen-2021 Fallica, Antonino N; Pittalà, Valeria; Modica, Maria N; Salerno, Loredana; Romeo, Giuseppe; Marrazzo, Agostino; Helal, Mohamed A; Intagliata, Sebastiano
Synthesis of “no-light activated” Ciprofloxacin and Norfloxacin derivatives as potential biofilm dispersant agents 1-gen-2019 Fallica, Antonino N.; Ciaffaglione, Valeria; Leonardi, Carmen; Dichiara, Maria; Barbaraci, Carla; Catalfo, Alfio; Finocchiaro, GUGLIELMO MARTINO; DE GUIDI, Guido; Amata, Emanuele; Marrazzo, Agostino
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. 1-gen-2018 Dichiara, M; Modica, Mn; Leonardi, C; Margani, F; Ciaffaglione, V; Fallica, An; Floresta, G; Gentile, D; Cosenza, J; Pittalà, V.